Barclays’s Citius Pharmaceuticals CTXR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-29
| Closed | – | – | 4379 |
|
|
2025
Q1 | $0 | Buy |
+29
| New | – | ﹤0.01% | 4402 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 4375 |
|
|
2024
Q3 | – | Sell |
-1,513
| Closed | -$22K | – | 4336 |
|
|
2024
Q2 | $22K | Sell |
1,513
-2,266
| -60% | -$32.9K | ﹤0.01% | 3883 |
|
|
2024
Q1 | $85K | Sell |
3,779
-2,974
| -44% | -$66.9K | ﹤0.01% | 3696 |
|
|
2023
Q4 | $128K | Buy |
6,753
+5,882
| +675% | +$111K | ﹤0.01% | 3650 |
|
|
2023
Q3 | $15K | Sell |
871
-109
| -11% | -$1.88K | ﹤0.01% | 3954 |
|
|
2023
Q2 | $29K | Buy |
+980
| New | +$29K | ﹤0.01% | 3878 |
|
|
2022
Q4 | – | Sell |
-135
| Closed | -$4K | – | 4399 |
|
|
2022
Q3 | $4K | Sell |
135
-129
| -49% | -$3.82K | ﹤0.01% | 4401 |
|
|
2022
Q2 | $6K | Sell |
264
-540
| -67% | -$12.3K | ﹤0.01% | 4434 |
|
|
2022
Q1 | $36K | Sell |
804
-4,709
| -85% | -$211K | ﹤0.01% | 4123 |
|
|
2021
Q4 | $212K | Buy |
5,513
+3,657
| +197% | +$141K | ﹤0.01% | 2811 |
|
|
2021
Q3 | $94K | Sell |
1,856
-247
| -12% | -$12.5K | ﹤0.01% | 3236 |
|
|
2021
Q2 | $183K | Buy |
2,103
+1,729
| +462% | +$150K | ﹤0.01% | 2928 |
|
|
2021
Q1 | $17K | Buy |
+374
| New | +$17K | ﹤0.01% | 3679 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 3691 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 3916 |
|